Literature DB >> 24468139

Flow patterns regulate hyperglycemia-induced subendothelial matrix remodeling during early atherogenesis.

Jonette Green1, Arif Yurdagul2, Marshall C McInnis1, Patrick Albert1, A Wayne Orr3.   

Abstract

OBJECTIVE: Altered subendothelial matrix composition regulates endothelial dysfunction and early atherosclerotic plaque formation. Hyperglycemia promotes endothelial matrix remodeling associated with multiple microvascular complications of diabetes, but a role for altered matrix composition in diabetic atherogenesis has not been described. Therefore, we sought to characterize the alterations in matrix composition during diabetic atherogenesis using both in vitro and in vivo model systems. METHODS AND
RESULTS: Streptozotocin-induced diabetes in atherosclerosis-prone ApoE knockout mice promoted transitional matrix expression (fibronectin, thrombospondin-1) and deposition in intima of the aortic arch as determined by qRT-PCR array and immunohistochemistry. Early plaque formation occurs at discrete vascular sites exposed to disturbed blood flow patterns, whereas regions exposed to laminar flow are protected. Consistent with this pattern, hyperglycemia-induced transitional matrix deposition was restricted to regions of disturbed blood flow. Laminar flow significantly blunted high glucose-induced fibronectin expression (mRNA and protein) and fibronectin fibrillogenesis in endothelial cell culture models, whereas high glucose-induced fibronectin deposition was similar between disturbed flow and static conditions.
CONCLUSIONS: Taken together, these data demonstrate that flow patterns and hyperglycemia coordinately regulate subendothelial fibronectin deposition during early atherogenesis.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Atherosclerosis; Endothelial; Fibronectin; Hyperglycemia; Shear stress

Mesh:

Substances:

Year:  2013        PMID: 24468139      PMCID: PMC3905249          DOI: 10.1016/j.atherosclerosis.2013.11.052

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  43 in total

1.  Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.

Authors:  David M Nathan; Patricia A Cleary; Jye-Yu C Backlund; Saul M Genuth; John M Lachin; Trevor J Orchard; Philip Raskin; Bernard Zinman
Journal:  N Engl J Med       Date:  2005-12-22       Impact factor: 91.245

2.  Inactivation of phosphorylated endothelial nitric oxide synthase (Ser-1177) by O-GlcNAc in diabetes-associated erectile dysfunction.

Authors:  Biljana Musicki; Melissa F Kramer; Robyn E Becker; Arthur L Burnett
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-05       Impact factor: 11.205

3.  Deletion of the alternatively spliced fibronectin EIIIA domain in mice reduces atherosclerosis.

Authors:  Michelle H Tan; Zhengwu Sun; Sarah L Opitz; Tracy E Schmidt; John H Peters; Elizabeth L George
Journal:  Blood       Date:  2004-02-19       Impact factor: 22.113

4.  Overexpression of fibronectin induced by diabetes or high glucose: phenomenon with a memory.

Authors:  S Roy; R Sala; E Cagliero; M Lorenzi
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

Review 5.  Inflammation in atherosclerosis: from pathophysiology to practice.

Authors:  Peter Libby; Paul M Ridker; Göran K Hansson
Journal:  J Am Coll Cardiol       Date:  2009-12-01       Impact factor: 24.094

6.  Elevated glucose attenuates agonist- and flow-stimulated endothelial nitric oxide synthase activity in microvascular retinal endothelial cells.

Authors:  Paul Connell; Tony Walshe; Gail Ferguson; Wei Gao; Colm O'Brien; Paul A Cahill
Journal:  Endothelium       Date:  2007 Jan-Feb

7.  Absence of correlation between coronary arterial atherosclerosis and severity or duration of diabetes mellitus of adult onset.

Authors:  V J Vigorita; G W Moore; G M Hutchins
Journal:  Am J Cardiol       Date:  1980-10       Impact factor: 2.778

8.  Reactive oxygen species mediate a cellular 'memory' of high glucose stress signalling.

Authors:  M A Ihnat; J E Thorpe; C D Kamat; C Szabó; D E Green; L A Warnke; Z Lacza; A Cselenyák; K Ross; S Shakir; L Piconi; R C Kaltreider; A Ceriello
Journal:  Diabetologia       Date:  2007-05-17       Impact factor: 10.122

9.  A selective matrix metalloproteinase-12 inhibitor retards atherosclerotic plaque development in apolipoprotein E-knockout mice.

Authors:  Jason L Johnson; Laurent Devel; Bertrand Czarny; Sarah J George; Christopher L Jackson; Vassilis Rogakos; Fabrice Beau; Athanasios Yiotakis; Andrew C Newby; Vincent Dive
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-01-06       Impact factor: 8.311

10.  The subendothelial extracellular matrix modulates NF-kappaB activation by flow: a potential role in atherosclerosis.

Authors:  A Wayne Orr; John M Sanders; Melissa Bevard; Elizabeth Coleman; Ian J Sarembock; Martin Alexander Schwartz
Journal:  J Cell Biol       Date:  2005-04-04       Impact factor: 10.539

View more
  17 in total

1.  Disturbed Flow Promotes Arterial Stiffening Through Thrombospondin-1.

Authors:  Chan Woo Kim; Anastassia Pokutta-Paskaleva; Sandeep Kumar; Lucas H Timmins; Andrew D Morris; Dong-Won Kang; Sidd Dalal; Tatiana Chadid; Katie M Kuo; Julia Raykin; Haiyan Li; Hiromi Yanagisawa; Rudolph L Gleason; Hanjoong Jo; Luke P Brewster
Journal:  Circulation       Date:  2017-08-04       Impact factor: 29.690

Review 2.  Blood Brothers: Hemodynamics and Cell-Matrix Interactions in Endothelial Function.

Authors:  Arif Yurdagul; A Wayne Orr
Journal:  Antioxid Redox Signal       Date:  2016-02-19       Impact factor: 8.401

Review 3.  Endothelial fluid shear stress sensing in vascular health and disease.

Authors:  Nicolas Baeyens; Chirosree Bandyopadhyay; Brian G Coon; Sanguk Yun; Martin A Schwartz
Journal:  J Clin Invest       Date:  2016-03-01       Impact factor: 14.808

4.  EphA2 Expression Regulates Inflammation and Fibroproliferative Remodeling in Atherosclerosis.

Authors:  Alexandra C Finney; Steven D Funk; Jonette M Green; Arif Yurdagul; Mohammad Atif Rana; Rebecca Pistorius; Miriam Henry; Andrew Yurochko; Christopher B Pattillo; James G Traylor; Jin Chen; Matthew D Woolard; Christopher G Kevil; A Wayne Orr
Journal:  Circulation       Date:  2017-05-09       Impact factor: 29.690

Review 5.  Integrin signaling in atherosclerosis.

Authors:  Alexandra C Finney; Karen Y Stokes; Christopher B Pattillo; A Wayne Orr
Journal:  Cell Mol Life Sci       Date:  2017-02-28       Impact factor: 9.261

6.  The Thrombospondin1-TGF-β Pathway and Glaucoma.

Authors:  Joanne E Murphy-Ullrich; J Crawford Downs
Journal:  J Ocul Pharmacol Ther       Date:  2015-05-29       Impact factor: 2.671

7.  Endothelial FN (Fibronectin) Deposition by α5β1 Integrins Drives Atherogenic Inflammation.

Authors:  Zaki Al-Yafeai; Arif Yurdagul; Jonette M Peretik; Mabruka Alfaidi; Patrick A Murphy; A Wayne Orr
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-11       Impact factor: 8.311

Review 8.  The arterial microenvironment: the where and why of atherosclerosis.

Authors:  Arif Yurdagul; Alexandra C Finney; Matthew D Woolard; A Wayne Orr
Journal:  Biochem J       Date:  2016-05-15       Impact factor: 3.857

9.  Integrin affinity modulation critically regulates atherogenic endothelial activation in vitro and in vivo.

Authors:  Zaki Al-Yafeai; Brenna H Pearson; Jonette M Peretik; Elizabeth D Cockerham; Kaylea A Reeves; Umesh Bhattarai; Dongdong Wang; Brian G Petrich; A Wayne Orr
Journal:  Matrix Biol       Date:  2020-11-04       Impact factor: 11.583

10.  Simvastatin Increases Fibulin-2 Expression in Human Coronary Artery Smooth Muscle Cells via RhoA/Rho-Kinase Signaling Pathway Inhibition.

Authors:  Noemí Serra; Roser Rosales; Lluís Masana; Joan-Carles Vallvé
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.